In the fourth quarter, Shell nudged up its dividend to $0.3580 and Shell CEO Wael Sawan launched a $3.5bn share buyback for ...

Bioxodes SA is gearing up fundraising for a follow-up study to the newly released interim phase IIa results of its lead asset in treating intracerebral hemorrhagic stroke. Data from the first 16 ...

We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to ...

Bill Gates became the youngest billionaire back in 1987 when he took Microsoft public, and he has been a billionaire since ...

TGTX surges 200% in 2023 on Briumvi's MS success. With Q1'25 earnings ahead, see here for TGTX stock's sales trends, new ...

Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...

Pharma advertisers have kicked off 2025 with a bang, with the top 10 spenders throwing almost 30% more money behind their TV ...

Detailed price information for Agnc Investment Corp (AGNC-Q) from The Globe and Mail including charting and trades.

The Sensex and Nifty are both expected to open with a gap-down on Thursday, April 17, according to the Gift Nifty, which is ...

Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growthStrategy builds on technology and science leadership, focusing on high-growth, high-value ...

Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector ...

The Management has withdrawn the suspension of operations order and has instead declared lockout at Walchandnagar Industries ...